McCay P B, Gibson D D, Hornbrook K R
Fed Proc. 1981 Feb;40(2):199-205.
Both enzymic and nonenzymic lipid peroxidation in membranes are inhibited by a)certain chelating compounds, b)some metal ion (Mn2+, Co2+, and Ce3+), and c)lipid soluble antioxidants. The commonalities suggest that the processes of oxidative lipid degradation in the two types of systems may be similar, differing only in the mechanism of initiation. This is further borne out by studies with a glutathione-dependent, heat-labile cytosolic factor that inhibits malondialdehyde formation (a product of lipid peroxidation) in both systems. Studies in the authors' laboratory, however, have demonstrated that the cytosolic factor protects membranous organelles from oxidative damage to the lipids by preventing peroxidation from occurring at all. Analyses of the fatty acid composition of the membranes demonstrate that the polyunsaturated fatty acid content remains stable when the membranes are subjected to peroxidizing conditions in the presence of the cytosolic factor and GSH. Both the cytosolic factor and GSH are required for the protective action since neither can provide this marked stabilizing effects by itself. High concentrations of GSH reduce lipid peroxidation to some extent, but low concentrations are not effective without the addition of the cytosolic factor. The mechanism of this inhibition of peroxidative attack is unknown. Partial purification of rat liver cytosolic glutathione peroxidase demonstrated that the heat-labile cytosolic factor was not glutathione peroxidase. The cytosolic factor may be a glutathione transferase, but that is not known with certainty. Possibly more than one cytosolic protein possesses this GSH-dependent property for inhibiting lipid peroxidation under conditions of oxidative stress. The conditions for the functioning of this protective system in intact cells appear to be optimum and it may constitute a ubiquitous membrane-stabilizing system in that it is also present in other tissues (heart and lung, for example).
a)某些螯合化合物;b)一些金属离子(Mn2+、Co2+和Ce3+);c)脂溶性抗氧化剂。这些共性表明,两种系统中氧化脂质降解的过程可能相似,只是引发机制不同。这一点通过对一种依赖谷胱甘肽的、热不稳定的胞质因子的研究得到了进一步证实,该因子在两种系统中均能抑制丙二醛的形成(脂质过氧化的产物)。然而,作者实验室的研究表明,胞质因子通过完全阻止过氧化反应的发生,保护膜性细胞器免受脂质氧化损伤。对膜脂肪酸组成的分析表明,当膜在胞质因子和谷胱甘肽存在的情况下处于过氧化条件时,多不饱和脂肪酸含量保持稳定。胞质因子和谷胱甘肽对于这种保护作用都是必需的,因为它们单独都不能提供这种显著的稳定作用。高浓度的谷胱甘肽在一定程度上可降低脂质过氧化,但低浓度时若无胞质因子的添加则无效。这种对过氧化攻击的抑制机制尚不清楚。大鼠肝脏胞质谷胱甘肽过氧化物酶的部分纯化表明,热不稳定的胞质因子不是谷胱甘肽过氧化物酶。胞质因子可能是一种谷胱甘肽转移酶,但这尚未确定。在氧化应激条件下,可能不止一种胞质蛋白具有这种依赖谷胱甘肽抑制脂质过氧化的特性。这种保护系统在完整细胞中发挥作用的条件似乎是最佳的,并且它可能构成一种普遍存在的膜稳定系统,因为它也存在于其他组织中(例如心脏和肺)。